Cargando…
Serotonin-Dopamine Interaction : Experimental Evidence and Therapeutic Relevance /
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the serotonin (5-HT)-dopamine (DA) interactions. Central serotonergic and dopaminergic systems play a critical role in the regulation of normal...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; New York :
Elsevier,
2008.
|
| Edición: | First edition. |
| Colección: | Progress in brain research ;
v. 172. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn301734016 | ||
| 003 | OCoLC | ||
| 005 | 20231117015213.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 090204s2008 ne af ob 011 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OCLCQ |d E7B |d OCLCQ |d QCL |d UBY |d OCLCQ |d MERUC |d OPELS |d OCLCQ |d NLGGC |d OPELS |d OCLCF |d CUS |d OCLCQ |d OCLCO |d CHVBK |d YDXCP |d AU@ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d UAB |d OTZ |d CASUM |d MEU |d OCLCO |d OCL |d D6H |d OCLCO |d VT2 |d OCLCO |d NLE |d OCLCO |d OCLCQ |d UKMGB |d YOU |d OCLCO |d OCLCA |d LEAUB |d INARC |d OCLCO |d OCLCA |d OCLCO |d COM |d OCLCO |d OCLCQ |d OCL | ||
| 015 | |a GBB6H5978 |2 bnb | ||
| 016 | 7 | |a 101491212 |2 DNLM | |
| 016 | 7 | |a 014787723 |2 Uk | |
| 016 | 7 | |a 017593415 |2 Uk | |
| 019 | |a 265717123 |a 515273119 |a 646767375 |a 695379202 |a 712980287 | ||
| 020 | |a 9780080932682 |q (electronic bk.) | ||
| 020 | |a 0080932681 |q (electronic bk.) | ||
| 020 | |a 9780444532350 |q (electronic bk.) | ||
| 020 | |a 0444532358 |q (electronic bk.) | ||
| 024 | 8 | |a 2900005 | |
| 035 | |a (OCoLC)301734016 |z (OCoLC)265717123 |z (OCoLC)515273119 |z (OCoLC)646767375 |z (OCoLC)695379202 |z (OCoLC)712980287 | ||
| 050 | 4 | |a QP376 |b .P7 v.172eb | |
| 060 | 4 | |a W1 |b PR667J v.172 2008 | |
| 060 | 4 | |a QV 126 |b S4851 2008 | |
| 072 | 7 | |a MED |x 057000 |2 bisacsh | |
| 072 | 7 | |a PSY |x 020000 |2 bisacsh | |
| 082 | 0 | 4 | |a 612.8042 |2 22 |
| 084 | |a 44.90 |2 bcl | ||
| 245 | 0 | 0 | |a Serotonin-Dopamine Interaction : |b Experimental Evidence and Therapeutic Relevance / |c edited by Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito. |
| 250 | |a First edition. | ||
| 264 | 1 | |a Amsterdam ; |a New York : |b Elsevier, |c 2008. | |
| 300 | |a 1 online resource (xv, 665 pages, 6 pages of plates) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Progress in brain research, |x 0079-6123 ; |v volume 172 | |
| 546 | |a Text in English. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the serotonin (5-HT)-dopamine (DA) interactions. Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviors. Moreover, recent evidence suggests that the dysfunction of the DA and 5-HT neurotransmitter systems contribute to various mental disorders including depression, schizophrenia, drug addiction and Parkinson?s disease. This extremely important topic is of wide interest within th. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a 1. SEROTONIN-DOPAMINE INTERACTIONS IN THE CENTRAL NERVOUS SYSTEM; 1. Serotonin-Dopamine Interaction: an overview; 2. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies; 3. Serotonin-Dopamine Interaction: electrophysiological evidence; 4. Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders; ; 2. SEROTONIN-DOPAMINE INTERACTIONS IN SCHIZOPHRENIA; 5. Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment; 6. Alterations of dopamine and serotonin transmission in schizophrenia; 7. Serotonin and dopamine interactions in psychosis prevention; 8. Role of serotonin and dopamine receptor binding in antipsychotic efficacy; 9. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems; 10. | |
| 505 | 0 | |a Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis; 11. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders; ; 3. SEROTONIN-DOPAMINE INTERACTIONS IN DEPRESSION; 12. The dorsal raphe nucleus and serotonin -implications for neuroplasticity linked to major depression and Alzheimer's disease; 13. Dynamics of the dopaminergic system as a key component to the understanding of depression; 14. Physiological and therapeutic relevance of constitutive activity of 5-HT2A and 5-HT2C receptors for the treatment of depression; 15. The role of dopamine and serotonin in suicidal behaviour and aggression; ; 4. SEROTONIN-DOPAMINE INTERACTIONS IN DRUG ADDICTION; 16. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse; 17. | |
| 505 | 0 | |a Pharmacological inhibition of dopamine- and serotonin activity blocks spontaneous and cocaine-activated behaviour; 18. Serotonin receptors as potential targets for modulation of nicotine use and dependence; 19. Dopamine/Serotonin releasers as medications for stimulant addictions; 20. PTEN-5-HT2C coupling: A new target for treating drug addiction; ; 5. SEROTONIN-DOPAMINE INTERACTIONS IN MOTOR DISORDERS; 21. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders; 22. Serotonin-Dopamine interaction in the induction and maintenance of LDOPA-induced dyskinesias; 23. Parkinson's disease -- opportunities for novel therapeutics to reduce the problems of levodopa therapy; 24. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome; ; 6. SEROTONIN-DOPAMINE INTERACTIONS IN ATTENTIONAL PROCESSES, LEARNING AND MEMORY; 25. | |
| 505 | 0 | |a Serotonergic and dopaminergic modulation of attentional processes; 26. Dopamine-serotonin interactions in attention-deficit/hyperactivity disorder (ADHD); 27. Serotonin/dopamine interaction in learning; 28. Serotonin-dopamine interaction in memory formation; 29. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. | |
| 650 | 0 | |a Serotonin |x Physiological effect |x Research. | |
| 650 | 0 | |a Serotonin |x Therapeutic use |x Research. | |
| 650 | 0 | |a Serotonin |x Antagonists |x Research. | |
| 650 | 0 | |a Dopamine |x Physiological effect |x Research. | |
| 650 | 0 | |a Dopamine |x Therapeutic use |x Research. | |
| 650 | 0 | |a Dopamine |x Agonists |x Research. | |
| 650 | 0 | |a Neurotransmitters |x Research. | |
| 650 | 0 | |a Neurochemistry. | |
| 650 | 0 | |a Drug interactions. | |
| 650 | 0 | |a Serotonin |x Agonists. | |
| 650 | 0 | |a Neurotransmitters. | |
| 650 | 0 | |a Serotonin. | |
| 650 | 0 | |a Dopamine. | |
| 650 | 1 | 2 | |a Dopamine |x physiology |0 (DNLM)D004298Q000502 |
| 650 | 1 | 2 | |a Serotonin |x physiology |0 (DNLM)D012701Q000502 |
| 650 | 2 | |a Neurochemistry |0 (DNLM)D009448 | |
| 650 | 2 | |a Neurotransmitter Agents |0 (DNLM)D018377 | |
| 650 | 2 | |a Serotonin |0 (DNLM)D012701 | |
| 650 | 2 | |a Dopamine |0 (DNLM)D004298 | |
| 650 | 2 | 2 | |a Dopamine Agonists |0 (DNLM)D018491 |
| 650 | 2 | 2 | |a Drug Interactions |0 (DNLM)D004347 |
| 650 | 2 | 2 | |a Serotonin Receptor Agonists |0 (DNLM)D017366 |
| 650 | 6 | |a Neurochimie. |0 (CaQQLa)201-0022100 | |
| 650 | 6 | |a Neurotransmetteurs. |0 (CaQQLa)201-0006023 | |
| 650 | 6 | |a S�erotonine. |0 (CaQQLa)201-0028510 | |
| 650 | 6 | |a Dopamine. |0 (CaQQLa)201-0047194 | |
| 650 | 6 | |a S�erotonine |0 (CaQQLa)201-0028510 |x Effets physiologiques |0 (CaQQLa)201-0374337 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a S�erotonine |0 (CaQQLa)201-0028510 |x Emploi en th�erapeutique |0 (CaQQLa)201-0373975 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a Antis�erotonines |0 (CaQQLa)201-0022914 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a Dopamine |0 (CaQQLa)201-0047194 |x Effets physiologiques |0 (CaQQLa)201-0374337 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a Dopamine |0 (CaQQLa)201-0047194 |x Emploi en th�erapeutique |0 (CaQQLa)201-0373975 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a Dopamine |0 (CaQQLa)201-0041499 |x Agonistes |0 (CaQQLa)201-0041499 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a Neurotransmetteurs |0 (CaQQLa)201-0006023 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a Interactions m�edicamenteuses. |0 (CaQQLa)201-0055133 | |
| 650 | 6 | |a S�erotonine |x Agonistes. |0 (CaQQLa)201-0317745 | |
| 650 | 7 | |a MEDICAL |x Neuroscience. |2 bisacsh | |
| 650 | 7 | |a PSYCHOLOGY |x Neuropsychology. |2 bisacsh | |
| 650 | 7 | |a Serotonin |x Agonists. |2 fast |0 (OCoLC)fst01113325 | |
| 650 | 7 | |a Serotonin. |2 fast |0 (OCoLC)fst01113324 | |
| 650 | 7 | |a Neurotransmitters. |2 fast |0 (OCoLC)fst01036566 | |
| 650 | 7 | |a Drug interactions. |2 fast |0 (OCoLC)fst00898681 | |
| 650 | 7 | |a Dopamine. |2 fast |0 (OCoLC)fst00896922 | |
| 650 | 7 | |a Neurochemistry. |2 fast |0 (OCoLC)fst01036329 | |
| 655 | 7 | |a Festschriften. |2 fast |0 (OCoLC)fst01941036 | |
| 655 | 7 | |a Festschriften. |2 lcgft | |
| 700 | 1 | |a Di Giovanni, Giuseppe, |e editor, |e dedicatee. | |
| 700 | 1 | |a Di Matteo, Vincenzo, |e editor. | |
| 700 | 1 | |a Esposito, Ennio, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Serotonin-dopamine interaction. |b 1st ed. |d Amsterdam ; Oxford : Elsevier, 2008 |z 9780444532350 |z 0444532358 |w (OCoLC)233617614 |
| 830 | 0 | |a Progress in brain research ; |v v. 172. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00796123/172 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780444532350 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/publication?issn=00796123&volume=172 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00796123 |z Texto completo |